Skip to main content

Profile of patients with diabetes in Eritrea: results of first phase registry analyses

Acta Diabetologica volume 47, pages 23–27 (2010)Cite this article

Abstract

A cross-sectional descriptive study was done on patients recently entered into the National Diabetes Registry in Eritrea where the prevalence was estimated to be 2.2% based on patient information in 2004. Of the 627 patients with diabetes, two thirds were type 2. Although type 1 had poorer control (42.9%) than type 2 (29.9%), some of the risk factors such as cholesterol (43.4 vs. 28.2%), triglyceride (23.4 vs. 12.8%), hypertension (55.2 vs. 12.7%) as well as BMI and waist/hip ratio were higher in type 2 than type 1. More than one-third (41.2%) of patients with type 2 compared to type 1 (19.5%) had complications, the commonest being retinopathy (33%) followed by foot ulcers (14%) and neuropathy (4%). Many of the diabetic patients demonstrated the presence of the metabolic syndrome components such as hypertension, obesity and dyslipidemia. The authors conclude that diabetes registry is invaluable in providing evidence-based prevention and control of the disease.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

43,34 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

References

  1. Adeghate E, Schattner P, Dunn E (2006) An update on the etiology and epidemiology of diabetes mellitus. Ann New York Acad Sci 1084:1–29

    Article  Google Scholar 

  2. Mbanya JC, Sobngwi E (2003) Diabetes in Africa diabetes micro vascular and macro vascular disease in Africa. J Cardiovasc Risk 10:97–102

    Article  PubMed  Google Scholar 

  3. Mufunda J, Nyarango P, Kosia A, Ogbamariam A, Mebrahtu G, Usman A et al (2005) Non-communicable diseases in Africa: a silent hypertension epidemic in Eritrea. J Hum Hypertens 19:255–256

    CAS  PubMed  Google Scholar 

  4. Mufunda J, Chatora R, Ndambakuwa Y, Nyarango P, Kosia A, Chifamba J et al (2006) Emerging non-communicable disease epidemic in Africa: preventive measures from the WHO Regional Office for Africa. Ethn Dis 16:521–526

    PubMed  Google Scholar 

  5. Usman A, Mebrahtu G, Mufunda J, Nyarango P, Hagos G, Kosia A et al (2006) Prevalence of non communicable disease risk factors in Eritrea. Ethn Dis 16:542–546

    PubMed  Google Scholar 

  6. Mufunda J, Mebrahtu G, Usman A, Nyarango P, Kosia A, Ghebrat Y, Ogbamariam A, Masjuan M, Gebremichael A (2006) Prevalence of hypertension in Eritrea and its relationship with obesity: results from a national blood pressure survey. J Hum Hypertens 20(1):59–65

    Article  CAS  PubMed  Google Scholar 

  7. Sharp P, Rainbow S (2002) Continuous glucose monitoring and hemoglobin A1C. Ann Clin Biochem 39:516–517

    Article  CAS  PubMed  Google Scholar 

  8. Manley S (2003) Haemoglobin A1c—a marker for complications of type 2 diabetes: the experience from the UK Prospective Diabetes Study (UKPDS). Clin Chem Lab Med 41:1182–1190

    Article  CAS  PubMed  Google Scholar 

  9. Carinci F, Federici MO, Benedetti MM (2006) Diabetes registers and prevention strategies: towards an active use of health information. Diabetes Res Clin Pract 74(Suppl 2):S215–S219

    Article  Google Scholar 

  10. Georgioou A, Burns J, McKenzie S, Penn D, Flack J, Harris MF (2006) Monitoring change in diabetes care using diabetes registers-experience from divisions of general practice. Aust Fam Phys 35:77–80

    Google Scholar 

  11. Abdul-Ghani M, Nawaf G, Nawaf F, Itzhak B, Minuchin O, Vardi P (2006) Increased prevalence of micro vascular complications in type 2 diabetes patients with the metabolic syndrome. Isr Med Assoc J 8:424–425

    Google Scholar 

  12. Swai AB, Kitange HM, Masuki G, Kilima PM, Alberti KG, McLarty DG (1992) Is diabetes mellitus related to undernutrition in rural Tanzania? BMJ 305:1057–1062

    Article  CAS  PubMed  Google Scholar 

  13. Cuissnier-Raynall JC, Ducorps M, Grandpierre G (1985) Tropical diabetes mellitus, a new nutritional indicator. Med Trop 45:179–184

    Google Scholar 

  14. Sleight P, Pouleur H, Zannad F (2006) Benefits, challenges, and registrability of the polypill. Eur Heart J 27:1651–1656

    Article  PubMed  Google Scholar 

  15. Gaziano TA, Opie LH, Weinsterin MC (2006) Cardiovascular disease prevention with a multidrug regimen in the developing world: a cost-effectiveness analysis. Lancet 368:679–686

    Article  CAS  PubMed  Google Scholar 

  16. Siraj ES, Sevoum B, Saenz C, Abdulkadir J (2006) Lipid and lipoprotein profiles in Ethiopians with diabetes mellitus. Metabolism 55:706–710

    Article  CAS  PubMed  Google Scholar 

  17. Kulenovic I, Rasic S, Karcic S (2006) Development of micro vascular complications in type 1 diabetic patients 10 years follow up. Bosn J Basic Med Sci 6:47–50

    PubMed  Google Scholar 

  18. Sokolnicki LA, Roberts SK, Wilkins BW, Basu A, Charkoudian N (2007) Contribution of nitric oxide to cutaneous micro vascular dilation in individuals with type 2 diabetes mellitus. Am J Physiol Endocrinol Metab 292:E314–E318

    Article  CAS  PubMed  Google Scholar 

  19. Kasaloya Z, Prazny M, Skrha J (2006) Relationship between peripheral diabetic neuropathy and micro vascular reactivity in patients with type 1 and type 2 diabetes mellitus—neuropathy and microcirculation. Exp Clin Endocrinol Diabet 114:52–57

    Article  Google Scholar 

  20. Ogbera AO, Fasanmade O, Ohwovoriole AE, Adediran O (2006) An assessment of the disease burden of foot ulcers in patients with diabetes mellitus attending a teaching hospital in Lagos, Nigeria. Int J Low Extrem Wounds 5:244–249

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

The authors are very grateful to the Ministry of Health for the permission granted to publish this work and to the WHO Eritrea Country for facilitating the publishing process.

Author information

Affiliations

  1. Division of Endocrinology, School of Medicine, Wayne State University , Detroit, MI, USA

    Berhane Seyum

  2. Division of Disease Prevention and Control, Ministry of Health, Asmara, Eritrea

    Goitom Mebrahtu & Ermias Negassi

  3. World Health Organization Eritrea Country Office, Asmara, Eritrea

    Abdulmumini Usman, Jacob Mufunda & Andrew Kosia

  4. Halibet Hospital, Asmara, Eritrea

    Beyene Tewolde & Solomon Haile

Authors
  1. Berhane Seyum
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Goitom Mebrahtu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Abdulmumini Usman
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jacob Mufunda
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Beyene Tewolde
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Solomon Haile
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Andrew Kosia
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Ermias Negassi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jacob Mufunda.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Seyum, B., Mebrahtu, G., Usman, A. et al. Profile of patients with diabetes in Eritrea: results of first phase registry analyses. Acta Diabetol 47, 23–27 (2010). https://doi.org/10.1007/s00592-009-0093-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00592-009-0093-8

Keywords

  • Diabetes registry
  • Eritrea
  • Metabolic syndrome